M2: Adrenoreceptor Antagonist Drugs Flashcards
Reversible agonist
Phentolamin & Prazosin
May be reversible or irreversible
Alpha receptor antagonism
Irreversible antagonist
Phenoxybenzamine
Dec peripheral vascular resistance leads to orthostatic hypotension and reflex tachycardia. Miosis. Nasal stuffiness. Dec resistance to urine outflow.
Alpha 1 receptor antagonist
Irreversible A1 antagonist. Inhibition of NE uptake. Blocks sero, acetyl & etc. Attenuation and potentiation of catecholamine induced vasoconstriction. Treatment for pheochromocytoma. Given per orem.
Phenoxybenzamine
Diagnosis for Pheochromocytoma
Measure VMA & Ultz
Metabolic product of catecholamine breakdown
VMA
Orthostatic hypo, tachy, nasal stuffiness, inhibition of ejaculation.
SE & AE of phenoxybenzamine
Competitive antagonist of A1 & A2 receptors. Dec peripheral vascular resistance. For pheochromocytoma
Phenotalamine
Highly selective for A1 receptors. Relaxation of arterial & venule smooth muscle . For BPH. Relaxation of prostate muscle. Mgt for HPN
Prazosin/Minipress
Reversible A1 antagonist. For HPN & BPH. Extensively metabolized in the liver. Not usually used for HPN.
Terazosin
Half life is 22hrs. Longer. For HPN & BPH.
Doxazosin
A1 antagonist. High bioavailability. Inhibition of contractions in prostate smooth muscles. Less effect on standing BP.
Tamsulosin
Hypersecretion of catecholamines. Hypertension, headache, palpitation & excessive sweating.
Pheochromocytoma
Mild to moderate systemic HPN. Major adverse effect is orthostatic hypotension.
Chronic HPN
Peripheral Vascular Dse: Ar blocking agents are not effective. For reynauds phenomenon
Prazosin & Phenyoxybenzamine
Urinary Obstruction
Prazisin, Doxasozine, Terazosin& tamsulosin